- Home
- CFBK vs NKTR Comparison
CFBK vs NKTR Comparison
Compare CFBK & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFBK
- NKTR
- Stock Information
- Founded
- CFBK 1892
- NKTR 1990
- Country
- CFBK United States
- NKTR United States
- Employees
- CFBK N/A
- NKTR N/A
- Industry
- CFBK Major Banks
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- CFBK Finance
- NKTR Health Care
- Exchange
- CFBK Nasdaq
- NKTR Nasdaq
- Market Cap
- CFBK 127.9M
- NKTR 125.5M
- IPO Year
- CFBK 1998
- NKTR 1994
- Fundamental
- Price
- CFBK $23.86
- NKTR $0.67
- Analyst Decision
- CFBK Buy
- NKTR Strong Buy
- Analyst Count
- CFBK 1
- NKTR 6
- Target Price
- CFBK $29.00
- NKTR $4.92
- AVG Volume (30 Days)
- CFBK 20.1K
- NKTR 1.9M
- Earning Date
- CFBK 05-06-2025
- NKTR 05-08-2025
- Dividend Yield
- CFBK 1.17%
- NKTR N/A
- EPS Growth
- CFBK N/A
- NKTR N/A
- EPS
- CFBK 2.28
- NKTR N/A
- Revenue
- CFBK $47,663,000.00
- NKTR $87,248,000.00
- Revenue This Year
- CFBK $35.39
- NKTR N/A
- Revenue Next Year
- CFBK $10.11
- NKTR N/A
- P/E Ratio
- CFBK $10.46
- NKTR N/A
- Revenue Growth
- CFBK 1.22
- NKTR N/A
- 52 Week Low
- CFBK $16.92
- NKTR $0.43
- 52 Week High
- CFBK $31.17
- NKTR $1.52
- Technical
- Relative Strength Index (RSI)
- CFBK 58.35
- NKTR 46.17
- Support Level
- CFBK $23.69
- NKTR $0.64
- Resistance Level
- CFBK $24.25
- NKTR $0.83
- Average True Range (ATR)
- CFBK 0.26
- NKTR 0.06
- MACD
- CFBK -0.09
- NKTR -0.00
- Stochastic Oscillator
- CFBK 37.31
- NKTR 25.45
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.